RBC cuts target for Chemours stock from USD 22.00 to USD 14.00

Published on 10/20/2026 at 20:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Chemours reported USD 1.59 billion revenue for the second quarter, down 1.5 percent. Chemours stock costs EUR 11.59 on October 20, 2026 at 7:53 p.m. CEST.

Analyst target and reporting date

RBC Capital Markets cut its Chemours target from USD 22.00 to USD 14.00 on October 12, 2026.
Second-quarter revenue was USD 1.59 billion, down 1.5 percent year over year.
Chemours stock costs EUR 11.59 at Lang & Schwarz on October 20, 2026 at 7:53 p.m. CEST.
Chemours is scheduled to report third-quarter results on November 5, 2026.

CC, US1638511089, Illustration mit AI erstellt.

RBC Capital Markets cut its price target for The Chemours Company from USD 22.00 to USD 14.00 in an October 12, 2026 research report, according to Markets Insider. The revised target is 7.53 percent above the USD 13.02 NYSE price at 1:59 p.m. ET on October 20, 2026. At Lang & Schwarz, the stock was trading at EUR 11.59 on October 20, 2026 at 7:53 p.m. CEST.

Second-quarter loss sets the backdrop

Chemours reported USD 1.59 billion in second-quarter 2026 revenue, down 1.5 percent from the prior-year quarter, while diluted earnings per share were a loss of USD 1.81. The figures are carried in the company analysis by Simply Wall St.

The company generated USD 158.00 million in operating cash flow in the second quarter, compared with USD 44.00 million of negative operating cash flow in the first quarter. That sequential swing gives the earnings discussion a second dimension beyond the reported loss.

Stock remains in a wide range

The NYSE price of USD 13.02 on October 20, 2026 stood between the 52-week low of USD 10.44 and high of USD 28.67. The market capitalization was USD 2.0 billion, and trading volume reached 1,333,483 shares by the quoted timestamp. The euro quote provides the German investor view, while the NYSE figures show the home-market position.

Valuation and next reporting date

The NYSE quote carried a negative price-to-earnings ratio of 6.55 and earnings per share of USD 0.72 in the structured market snapshot. Chemours is scheduled to report third-quarter 2026 results on November 5, 2026, according to MarketBeat.

Comparison with peers

The Chemours Company: price-to-earnings ratio minus 6.55, market capitalization USD 2.0 billion. DuPont de Nemours (NYSE, USD): up 2.11 percent, price-to-earnings ratio 293.33, market capitalization USD 17.8 billion. Tronox Holdings (NYSE, USD): up 0.15 percent, price-to-earnings ratio minus 0.98, market capitalization USD 539.0 million.

What the target reset means

RBC's lower target places the emphasis on demand recovery and earnings execution rather than on a simple valuation re-rating. The November 5 results date gives investors the next scheduled checkpoint for revenue, cash generation and the path out of the second-quarter loss.

Price and investor perspective

The stock was trading at EUR 11.59 at Lang & Schwarz on October 20, 2026 at 7:53 p.m. CEST, while its home-market quote was USD 13.02 on the NYSE at 1:59 p.m. ET on the same date.

The further course of trading is shown by the continuously updated real-time quote of Chemours stock.